{"id":549974,"date":"2026-07-20T04:35:30","date_gmt":"2026-07-20T04:35:30","guid":{"rendered":"https:\/\/www.newsbeep.com\/il\/549974\/"},"modified":"2026-07-20T04:35:30","modified_gmt":"2026-07-20T04:35:30","slug":"samsung-biologics-to-buy-swiss-polypeptide-group-in-1-8-billion-deal","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/il\/549974\/","title":{"rendered":"Samsung Biologics to buy Swiss PolyPeptide Group in $1.8 billion deal"},"content":{"rendered":"<p>Photo illustration of a group of weight loss medications on a white background.<\/p>\n<p>Ucg | Universal Images Group | Getty Images<\/p>\n<p>South Korea&#8217;s Samsung Biologics said on Monday that it had made an all-cash bid of 1.46 billion Swiss francs ($1.8 billion) for Switzerland&#8217;s PolyPeptide Group, which specializes in peptide-based active pharmaceutical ingredients. <\/p>\n<p>Under the terms of the public tender offer, stockholders will receive 44.31 Swiss franc per share. The transaction is expected to close by the end of this year.\u00a0<\/p>\n<p>The acquisition will be the largest biopharmaceutical M&amp;A deal in the country&#8217;s history, Samsung Biologics said, as it aims to diversify its portfolio by expanding into peptide therapeutics, one of the fastest-growing segments in the biopharmaceutical industry due to surging demand for obesity treatment. <\/p>\n<p>Peptide therapeutics are medicines made from short chains of amino acids, including some GLP-1 obesity and diabetes drugs that mimic a natural hormone to reduce appetite and regulate blood sugar.<\/p>\n<p>&#8220;After a comprehensive review of strategic options, the Board is convinced that Samsung Biologics&#8217; offer is compelling for our shareholders, delivering an attractive cash price and immediate, certain value today,&#8221; said Peter Wilden, chairman, PolyPeptide.<\/p>\n<p>Samsung Biologics said that the acquisition will <a href=\"https:\/\/samsungbiologics.com\/media\/company-news\/samsung-biologics-announces-all-cash-offer-to-acquire-polypeptide\" target=\"_blank\" rel=\"nofollow noopener\">broaden the scope of<\/a> its existing offerings centered on antibody drugs and antibody-drug conjugates. The South Korean firm also seeks to meet growing client demand across a broader range of therapeutic modalities, driven by peptide-based GLP-1 therapies for obesity and diabetes.<\/p>\n<p>The deal will also expand Samsung Biologics&#8217; global footprint by securing PolyPeptide&#8217;s global network across Sweden, Belgium, France, the U.S. and India, encompassing its R&amp;D, development, and commercial manufacturing capabilities.<\/p>\n<p>Headquartered in Baar, Switzerland, PolyPeptide Group, which was spun off in 1996 from global pharmaceutical company Ferring, has\u00a0a track record of developing and producing more than 1,000 therapeutic peptides.\u00a0<\/p>\n<p>Samsung Biologics shares slipped 1.3% early Monday.<\/p>\n<p><a href=\"https:\/\/www.google.com\/preferences\/source?q=https:\/\/www.cnbc.com\/\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Photo illustration of a group of weight loss medications on a white background. Ucg | Universal Images Group&hellip;\n","protected":false},"author":2,"featured_media":549975,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[114,357,85,46,3950,2966],"class_list":["post-549974","post","type-post","status-publish","format-standard","has-post-thumbnail","category-business","tag-business","tag-business-news","tag-il","tag-israel","tag-switzerland","tag-world-markets"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/549974","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/comments?post=549974"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/549974\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media\/549975"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media?parent=549974"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/categories?post=549974"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/tags?post=549974"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}